You are currently viewing the editor's summary.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Analgesic TRPV1
Opiates provide pain relief, but they are addictive, and patients often become desensitized to them and then require greater doses. Inflammation, which is common with painful injuries, enhances the analgesic efficacy of opioids. Basso et al. found that inflammation-induced activation of the channel TRPV1 promoted opioid sensitivity and analgesia in mice by relocalizing the protein β-arrestin2 within the cell such that it could not interact with the μ-opioid receptor and facilitate its desensitization. This finding potentially explains the analgesic effect of inflammation in patients taking opioids and may identify ways to therapeutically prevent the need for opiate dose escalation.
This is an article distributed under the terms of the Science Journals Default License.
